Tag Archives: Tumor Antibody

New Drugs for Multiple Myeloma! Sanofi CD38 Targeted Antibody Therapy – Isatuximab’s First Phase III Clinical Study was Successful

French pharmaceutical giant Sanofi recently announced that the key phase III clinical study ICARIA-MM to evaluate isatuximab in the treatment of recurrent/refractory multiple myeloma (R/R MM) has reached the main end point. TheRead More…